Antigenic variability in Neuraminidase protein of Influenza A/H3N2 vaccine strains (1968 - 2009)

被引:1
|
作者
Shil, Pratip [1 ]
Chavan, Sameer S. [1 ]
Cherian, Sarah S. [1 ]
机构
[1] Natl Inst Virol, Bioinformat & Data Management Div, 20A Dr Ambedkar Rd, Pune 411001, Maharashtra, India
关键词
Influenza virus; H3N2; neuraminidase; antibody; molecular docking; antigenic drift; host-pathogen interaction; Mem5;
D O I
暂无
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Antigenic drift and shift involving the surface proteins of Influenza virus gave rise to new strains that caused epidemics affecting millions of people worldwide over the last hundred years. Variations in the membrane proteins like Hemagglutinin (HA) and Neuraminidase (NA) necessitates new vaccine strains to be updated frequently and poses challenge to effective vaccine design. Though the HA protein, the primary target of the human immune system, has been well studied, reports on the antigenic variability in the other membrane protein NA are sparse. In this paper we investigate the molecular basis of antigenic drift in the NA protein of the Influenza A/H3N2 vaccine strains between 1968 and 2009 and proceed to establish correlation between antigenic drift and antigen-antibody interactions. Sequence alignments and phylogenetic analyses were carried out and the antigenic variability was evaluated in terms of antigenic distance. To study the effects of antigenic drift on the protein structures, 3D structure of NA from various strains were predicted. Also, rigid body docking protocol has been used to study the interactions between these NA proteins and antibody Mem5, a 1998 antibody.
引用
收藏
页码:76 / 81
页数:6
相关论文
共 50 条
  • [31] A computational analysis of the antigenic properties of haemagglutinin in influenza A H3N2
    Lees, William D.
    Moss, David S.
    Shepherd, Adrian J.
    BIOINFORMATICS, 2010, 26 (11) : 1403 - 1408
  • [32] Influenza Vaccine Effectiveness: Defining the H3N2 Problem
    Belongia, Edward A.
    McLean, Huong Q.
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (10) : 1817 - 1823
  • [33] A sensitive and specific ELISA immunocapture assay for rapid quantitation of influenza A/H3N2 neuraminidase protein
    Gerentes, L
    Kessler, N
    Aymard, M
    JOURNAL OF VIROLOGICAL METHODS, 1998, 73 (02) : 185 - 195
  • [34] Mismatched hemagglutinin and neuraminidase activities in recent H3N2 influenza viruses
    Gulati, U
    Wu, WX
    Gulati, S
    Waner, JL
    Air, GM
    GLYCOBIOLOGY, 2004, 14 (11) : 1178 - 1179
  • [35] Prevalence and mechanisms of evolutionary contingency in human influenza H3N2 neuraminidase
    Ruipeng Lei
    Timothy J. C. Tan
    Andrea Hernandez Garcia
    Yiquan Wang
    Meghan Diefenbacher
    Chuyun Teo
    Gopika Gopan
    Zahra Tavakoli Dargani
    Qi Wen Teo
    Claire S. Graham
    Christopher B. Brooke
    Satish K. Nair
    Nicholas C. Wu
    Nature Communications, 13
  • [36] Prevalence and mechanisms of evolutionary contingency in human influenza H3N2 neuraminidase
    Lei, Ruipeng
    Tan, Timothy J. C.
    Garcia, Andrea Hernandez
    Wang, Yiquan
    Diefenbacher, Meghan
    Teo, Chuyun
    Gopan, Gopika
    Dargani, Zahra Tavakoli
    Teo, Qi Wen
    Graham, Claire S.
    Brooke, Christopher B.
    Nair, Satish K.
    Wu, Nicholas C.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [37] A(H3N2) antigenic variation of influenza is associated with low vaccine efficacy in the early 2018 influenza season in Mexico City
    Hernandez-Hernandez, Victor Alberto
    Higuera-Iglesias, Anjarath Lorena
    Palma-Cortes, Gabriel
    Tapia-Trejo, Daniela
    Avila-Rios, Santiago
    Gonzalez-Fernandez, Ruben Roberto
    Perez-Moreno, Luis Angel
    Zuniga-Ramos, Joaquin Alejandro
    Guadarrama-Perez, Cristobal
    Sandoval-Gutierrez, Jose Luis
    Cabello-Gutierrez, Carlos
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 125 : 114 - 119
  • [38] Neutralization potency of the 2023-24 seasonal influenza vaccine against circulating influenza H3N2 strains
    Huang, Xiande
    Cheng, Ziqi
    Lv, Yake
    Li, Weixuan
    Liu, Xiaoyu
    Huang, Weijin
    Zhao, Chenyan
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2024, 20 (01)
  • [39] Molecular and antigenic evolution of human influenza A/H3N2 viruses in Quebec, Canada, 2009-2011
    Ann, Julie
    Papenburg, Jesse
    Bouhy, Xavier
    Rheaume, Chantal
    Hamelin, Marie-Eve
    Boivin, Guy
    JOURNAL OF CLINICAL VIROLOGY, 2012, 53 (01) : 88 - 92
  • [40] The evolutionary footprint of influenza A subtype H3N2 strains in Bangladesh: implication of vaccine strain selection
    Sezanur Rahman
    Mehedi Hasan
    Md Shaheen Alam
    K. M. Main Uddin
    Sayra Moni
    Mustafizur Rahman
    Scientific Reports, 12